| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC3271 |
| Trial ID | NCT05648994 |
| Disease | Solid Tumor |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | NY-ESO-1 TCR-T cells |
| Co-treatment | Albumin-bound paclitaxel |
| HLA | HLA-A2 (except HLA-A*0203) |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Single-arm, Open-label, Dose-finding Clinical Study of TCR-T Cells in Patients With HLA-A2-expressing and NY-ESO-1-positive Recurrent or Metastatic Solid Tumors |
| Year | 2022 |
| Country | China |
| Company sponsor | Fujian Cancer Hospital |
| Other ID(s) | FJ002 |
| Cohort 1 | |||||||||
|
|||||||||